Kenneth Kernen

Dose Escalation Improves Cancer-Related Events at 10 Years for Intermediate- and High-Risk Prostate Cancer Patients Treated With Hypofractionated High-Dose-Rate Boost and External Beam Radiotherapy

Alvaro A. Martinez, Jose A. Gonzalez, Hong Ye et al. · International Journal of Radiation Oncology*Biology*Physics · 2011 · 160 citations

Medicine, Oncology, Radiation Oncology +17

Prostate-Specific Antigen Response and Systemic T Cell Activation After <i>In Situ</i> Gene Therapy in Prostate Cancer Patients Failing Radiotherapy

Brian J. Miles, Moshe Shalev, Estuardo Aguilar-Córdova et al. · Human Gene Therapy · 2001 · 95 citations

Medicine, Immunology, Oncology +17

Phase I/II trial evaluating combined radiotherapy and in situ gene therapy with or without hormonal therapy in the treatment of prostate cancer—A preliminary report

Bin S. Teh, Estuardo Aguilar-Cordova, Kenneth Kernen et al. · International Journal of Radiation Oncology*Biology*Physics · 2001 · 91 citations

Medicine, Oncology, Urology +17

Clinicopathologic analysis of extracapsular extension in prostate cancer: Should the clinical target volume be expanded posterolaterally to account for microscopic extension?

K. Chao, Neal S. Goldstein, Di Yan et al. · International Journal of Radiation Oncology*Biology*Physics · 2006 · 84 citations

Medicine, Oncology, Surgery +17

Impact of a Prostate Multidisciplinary Clinic Program on Patient Treatment Decisions and on Adherence to NCCN Guidelines

Howard Korman, Thomas Lanni, Chirag Shah et al. · American Journal of Clinical Oncology · 2012 · 70 citations

Medicine, Oncology, Urology +17